| Revenue growth | 29.3% YoY for FY26; 42.6% for Q4FY26. |
|---|---|
| Margins | EBITDA margin improved from 3.4% to 4.0% YoY. |
| Demand visibility | Strong, outperforming Indian Pharmaceutical Market (IPM) growth. |
| Management confidence | High, citing renewed confidence for FY27 momentum. |
Growth
FY26 revenue up 29.3% YoY; Q4FY26 revenue up 42.6%. FY26 PAT grew 35.7% to ₹145.8 Cr.
Outlook
FY27 guidance: 23% revenue growth, 5.0% EBITDA margin, and 50% OCF/EBITDA conversion. MedTech to cross ₹1,000 Cr.
Risks
Fragmented market competition, regulatory changes, and integration of numerous acquisitions.
Earnings Call filed with BSE, NSE: ENTERO. Summary written with AI assistance from the document.
Entero Healthcare Solutions Ltd: key numbers
- Share price
- ₹1,713.30
- Market cap
- ₹7,457 Cr
- Revenue (annual)
- ₹6,591 Cr
- Net profit (annual)
- ₹115.0 Cr
- P/E (TTM)
- 59.5×Sector 53.1×
- Promoter holding
- 52.40%-0.02% QoQ
- FII holding
- 4.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Entero Healthcare Solutions Ltd
All →Entero Healthcare Solutions Capital Structure Change
Surbhi Singh (Prasid Uno Family Trust), a non-promoter, sold 21.30 lakh Entero Healthcare shares via bulk/block deals. Stake fell from 7.94% to 3.05%; no transaction value disclosed.
Entero Healthcare Solutions Legal & Regulatory
Entero Healthcare Solutions reported a GST penalty of Rs. 0.13 Crore imposed on its subsidiary, ACE Cardiopathy Solutions, for non-generation of an E-Invoice.
- Value
- ₹0.13 Cr
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions Ltd filed its quarterly shareholding pattern for the period ended March 31, 2026, as per regulatory requirements.
Entero Healthcare Solutions Capital Structure Change
Prasid Uno Family Trust acquired 10,88,500 shares (2.50%) of Entero Healthcare Solutions Ltd via a block deal. Post-transaction, their total stake is 6.93%.
Entero Healthcare Solutions Management Change
Entero Healthcare Solutions announced the completion of the tenure of Non-Executive Independent Director Mr. Rajesh Shashikant Dalal, effective from August 24, 2026.
Entero Healthcare Solutions Annual General Meeting
Entero Healthcare Solutions Ltd held its 8th Annual General Meeting on August 19, 2026. Members approved all resolutions, including financial statement adoption and director re-appointments.